Article Under Review
This article is undergoing editorial and medical review. We regularly update content as part of our commitment to providing patient-centered, accurate, evidence-based information.
Overview
Most donors give once and that is enough. But sometimes your recipient needs donor cells again. If you are asked and choose to donate again, your body can do it. If you decide not to, that is completely okay. This choice is always yours alone.
Re-donation might be needed if the first transplant did not work as hoped, if the disease came back, or if additional cells could help. Your doctors will explain the medical reasons. But knowing why does not obligate you to say yes. Your health matters as much as the recipient's needs. Support from your coordination center and counselors is available as you think this through.
Can you donate again?
Yes, you can donate again if asked and if you're willing. Your body regenerated after the first donation and is ready to donate again if needed. Multiple donations are possible, though uncommon. A few donors have donated three or more times over their lifetime, and their donated cells helped multiple recipients.
Eligibility for re-donation depends on your health. If you've developed a medical condition that would disqualify you (cancer, serious infection, cardiac disease), you might not be eligible. If you're healthy, re-donation is medically possible. Your donation center will re-evaluate your health before asking you to donate again.
Your decision is completely voluntary. Even if you're medically eligible, you can decline to donate again. Your recipient's team will pursue other options, including searching for alternative donors or exploring different treatment approaches. Declining doesn't make you a bad person—donation is always optional, even for a second time.
- Re-donation is medically possible
- You must be healthy
- It's entirely voluntary
- Declining is always acceptable
- Your choice is respected
When you might be asked again
Re-donation is requested for several reasons. Common clinical indications include:
- Graft failure. Original transplant failed to engraft or cells were lost
- Delayed engraftment. Cells took too long to engraft, additional cells needed
- Relapse. Original disease recurred, second transplant needed
- Donor lymphocyte infusion (DLI). Additional donor immune cells to fight disease
- Graft manipulation. Research protocols needing cells for specialized testing
If your recipient needs you, your coordination center will contact you. They'll explain the clinical situation, what donation would involve, your health status, and timeline. You'll have time to ask questions and consider your decision.
The process the second time
PBSC re-donation
If PBSC collection is needed again, the process is similar to the first time: mobilization with filgrastim (4-6 days), CD34+ count monitoring, apheresis collection (2-4 hours). You'll experience the same bone pain during mobilization, the same collection experience.
You know what to expect because you've done it. Many donors find the second donation emotionally easier because they know it's manageable. Physically, the experience is the same.
Re-mobilization characteristics:
- Similar filgrastim mobilization protocol (4-6 days)
- CD34+ counts may vary from first donation
- Apheresis collection takes 2-4 hours typically
- Bone pain similar to first collection experience
- Some donors mobilize differently second time
Bone marrow re-donation
If bone marrow collection is needed again, it's a repeat surgical procedure: general anesthesia, marrow aspiration, hospital stay, recovery. Similar pain, similar recovery timeline. You know what to expect.
Re-collection might be from the same site (posterior ilium) or a different site to avoid excessive trauma to one location. The procedure is essentially the same regardless of site.
Donor lymphocyte infusion (DLI)
DLI involves collecting immune cells (lymphocytes) from your blood. Sometimes this is done via apheresis (similar to PBSC collection). Sometimes it's done via leukapheresis (similar technology, collecting specific white cells).
DLI advantages:
- Often faster than PBSC collection
- Requires fewer total cells collected
- Procedure typically takes 1-2 hours
- Less intensive than full stem cell collection
- Faster recovery than full collection
Your right to decline
You can decline to donate again. This is your decision to make. Reasons you might decline include:
- You don't want to go through the donation process again
- Your health has changed and you don't feel well enough
- Your personal circumstances have changed (work demands, family needs, caregiver responsibilities)
- You have complicated feelings about your previous donation or the recipient's outcome
- You simply changed your mind
Why declining is acceptable:
- Declining is not selfish or wrong
- Your recipient's team has backup plans
- Alternative treatments may be available
- Your welfare matters as much as recipient's need
- Backup donors or therapies can be pursued
Some donors feel guilt about declining re-donation. This guilt is understandable but not justified. You already gave something precious. You're not obligated to give again, even if the recipient needs it. Your autonomy is respected.
If uncertain about re-donation:
- Your coordination center can help you work through feelings
- Counseling is available to talk through the decision
- You don't have to decide immediately
- Time is available to carefully consider
Other ways to help
If you decline re-donation but want to continue helping, there are other ways:
- Advocacy and mentoring. Volunteer with organizations or mentor new donors
- Research participation. Participate in donor research or outcome studies
- Fundraising. Support registry organizations or transplant programs
- Emotional support. Connect with other donors or participate in support groups
- Lifestyle engagement. Stay involved in the transplant community
Helping doesn't always mean donating again. It can mean supporting the transplant community in many ways.
Additional Detailed Information
Additional Information
Clinical indications for re-donation
Graft failure definitions. Primary graft failure occurs when donor cells never engraft—recipient never achieves sufficient donor cell numbers to restore blood-forming capacity. Secondary graft failure occurs when donor cells initially engraft, then are lost. Both require new stem cell source or new donor.
Relapse characteristics. Relapse—recurrence of the original disease—can occur months to years after transplant. If disease recurs, recipients often undergo salvage transplant. Using the original donor (if available and willing) might be preferred if the first transplant successfully controlled disease initially.
Donor lymphocyte infusion. DLI involves infusing donor-derived T-lymphocytes to enhance graft-versus-tumor effect or restore immunity. DLI is used for relapse, mixed chimerism, or infectious disease complications. Collection is often performed via leukapheresis or sometimes via simple blood draw.
Re-mobilization considerations
G-CSF response variability. Some donors mobilize better on second G-CSF exposure; others mobilize less well. Factors affecting re-mobilization include time since first donation (longer time = better mobilization), current fitness level, and medication use. Response is unpredictable and can differ substantially from first donation.
Stem cell quality. Stem cells collected at re-donation appear similar in viability and function to first-collection cells. Age-related decline in hematopoietic stem cell number and function occurs gradually over years, so recently re-donated cells are typically high quality.
Informed re-donation consent
Re-informed consent. Donors undergoing repeat donation must again provide informed consent. The consent addresses risks, benefits, and alternatives specific to repeat donation. Health status changes and new medical developments might affect risk profile for re-donation.
Second donation outcomes
Outcome data for repeat donations. Published data on outcomes of repeat donor stem cell collections show similar engraftment rates and patient outcomes to first-time donations. Donor safety profiles remain similar—no increased complications in repeat donors.
Written By:
Transplants.org Staff
Last Reviewed: February 26, 2026
Informed By:
Transplants.org, with participation from 23 leading U.S. transplant centers, led the largest comparative analysis of patient educational materials in transplant history. We recognize the participating centers who helped inform and inspire our direction with initial patient-centered educational content:
- Mayo Clinic (Co-Author)
- Vanderbilt University Medical Center (Co-Author)
- Johns Hopkins Hospital (Co-Author)
- UCLA Medical Center (Co-Author)
- UCSF Medical Center (Co-Author)
Transplants.org is an independent nonprofit organization and participation is not an endorsement by these organizations.
